Get the Stockscreener App
0.5551
5.61%
-0.033
After Hours:
.58
0.0249
+4.49%
Tevogen Bio Holdings Inc stock is traded at $0.5551, with a volume of 339.59K.
It is down -5.61% in the last 24 hours and down -17.63% over the past month.
Tevogen Bio Holdings Inc a clinical-stage specialty immunotherapy company harnessing CD8+ cytotoxic T lymphocytes (CD8+ CTLs or CTLs), to develop off-the-shelf, precision T cell therapies for the treatment of infectious diseases, cancers, and neurological disorders.
See More
Previous Close:
$0.5881
Open:
$0.571
24h Volume:
339.59K
Relative Volume:
0.44
Market Cap:
$109.19M
Revenue:
-
Net Income/Loss:
$52.50M
P/E Ratio:
19.08
EPS:
0.0291
Net Cash Flow:
$-4.13M
1W Performance:
-8.22%
1M Performance:
-17.63%
6M Performance:
-45.04%
1Y Performance:
-71.68%
1-Day Range:
$0.5522
$0.59
1-Week Range:
$0.5522
$0.6363
52-Week Range:
$0.5522
$2.07
Tevogen Bio Holdings Inc Stock (TVGN) Company Profile
Name
Tevogen Bio Holdings Inc
Sector
Industry
Phone
646-807-8832
Address
15 INDEPENDENCE BOULEVARD, SUITE #210, WARREN
Compare TVGN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TVGN
Tevogen Bio Holdings Inc
|
0.5551 | 115.68M | 0 | 52.50M | -4.13M | 0.0291 |
|
VRTX
Vertex Pharmaceuticals Inc
|
421.67 | 109.22B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
628.00 | 67.50B | 14.25B | 4.58B | 3.88B | 41.77 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
423.47 | 57.35B | 3.21B | 43.57M | 221.36M | 0.2405 |
|
ARGX
Argen X Se Adr
|
831.48 | 50.87B | 3.06B | 1.28B | 447.35M | 19.67 |
|
INSM
Insmed Inc
|
182.77 | 39.72B | 447.02M | -1.18B | -868.57M | -6.1812 |
Tevogen Bio Holdings Inc Stock (TVGN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-04-25 | Initiated | D. Boral Capital | Buy |
Tevogen Bio Holdings Inc Stock (TVGN) Latest News
Analyzing net buyer seller activity in Tevogen Bio Holdings Inc. Equity WarrantTrade Signal Summary & Consistent Return Strategy Ideas - newser.com
Why Tevogen Bio Holdings Inc. (G28) stock stays on top picksEarnings Trend Report & Daily Oversold Stock Bounce Ideas - newser.com
Tevogen Bio Holdings Inc. Equity Warrant’s volatility index tracking explainedCPI Data & Community Consensus Stock Picks - newser.com
What’s next for Tevogen Bio Holdings Inc. Equity Warrant stock priceEarnings Summary Report & Growth Oriented Trade Recommendations - newser.com
What MACD and RSI say about Tevogen Bio Holdings Inc.2025 Stock Rankings & High Yield Equity Trading Tips - newser.com
News impact scoring models applied to Tevogen Bio Holdings Inc. Equity Warrant2025 AllTime Highs & Low Drawdown Investment Strategies - newser.com
How to monitor Tevogen Bio Holdings Inc. with trend dashboardsTreasury Yields & Technical Pattern Based Buy Signals - newser.com
Real time social sentiment graph for Tevogen Bio Holdings Inc. Equity Warrant2025 Risk Factors & Consistent Profit Trading Strategies - newser.com
Heatmap analysis for Tevogen Bio Holdings Inc. and competitors2025 Year in Review & Consistent Profit Focused Trading Strategies - newser.com
Why Tevogen Bio Holdings Inc. (G28) stock stays undervaluedQuarterly Portfolio Report & Technical Confirmation Alerts - newser.com
Will Tevogen Bio Holdings Inc. Equity Warrant stock recover after recent dropPortfolio Growth Summary & Daily Technical Stock Forecast Reports - newser.com
Multi asset correlation models including Tevogen Bio Holdings Inc. Equity WarrantJuly 2025 Trade Ideas & Technical Entry and Exit Alerts - newser.com
Is a relief rally coming for Tevogen Bio Holdings Inc. Equity Warrant holdersWeekly Investment Recap & Entry Point Confirmation Signals - newser.com
Can swing trading help recover from Tevogen Bio Holdings Inc. lossesQuarterly Profit Summary & Fast Momentum Entry Tips - newser.com
Can Tevogen Bio Holdings Inc. rally from current levels2025 Year in Review & Proven Capital Preservation Tips - newser.com
Why retail investors pile into Tevogen Bio Holdings Inc. stockJuly 2025 Highlights & Consistent Growth Stock Picks - newser.com
Tevogen Clarifies Reported Financials, Highlighting Strong Capital Efficiency and Low Cash Burn - The Manila Times
Tevogen Bio Addresses Accumulated Deficit and Provides Clarification on Financial Metrics Following Q3 2025 Filing - Quiver Quantitative
How hedge fund analytics apply to Tevogen Bio Holdings Inc. Equity Warrant stockPortfolio Value Summary & Daily Stock Trend Watchlist - newser.com
When is the best time to exit Tevogen Bio Holdings Inc.Earnings Beat & Expert Curated Trade Setups - newser.com
Can Tevogen Bio Holdings Inc. stock double in next 5 yearsTrade Volume Summary & High Accuracy Trade Signal Alerts - newser.com
Is Tevogen Bio Holdings Inc. (G28) stock a top dividend aristocrat candidateJuly 2025 Analyst Calls & Daily Stock Trend Watchlist - newser.com
Visual trend scoring systems applied to Tevogen Bio Holdings Inc. Equity Warrant2025 Technical Patterns & AI Driven Price Predictions - newser.com
What is the fair value of Tevogen Bio Holdings Inc. Equity Warrant stock nowWeekly Earnings Recap & Technical Entry and Exit Alerts - newser.com
How high can Tevogen Bio Holdings Inc. Equity Warrant stock goTrade Risk Summary & Reliable Entry Point Trade Alerts - newser.com
Can Tevogen Bio Holdings Inc. Equity Warrant recover in the next quarter2025 Price Targets & Precise Trade Entry Recommendations - newser.com
Published on: 2025-11-03 05:03:20 - newser.com
Why Tevogen Bio Holdings Inc. (G28) stock trades below fair valueJuly 2025 Analyst Calls & AI Enhanced Trading Signals - newser.com
Is Tevogen Bio Holdings Inc. Equity Warrant forming a bottoming baseQuarterly Profit Review & Daily Price Action Insights - newser.com
Is Tevogen Bio Holdings Inc. Equity Warrant stock near bottom after declineTrade Signal Summary & Free Safe Capital Growth Stock Tips - newser.com
Is Tevogen Bio Holdings Inc. (G28) stock vulnerable to rate hikesChart Signals & Community Trade Idea Sharing Platform - newser.com
What earnings margins imply for Tevogen Bio Holdings Inc. (G28) stock2025 Winners & Losers & Precise Trade Entry Recommendations - newser.com
Can momentum traders help lift Tevogen Bio Holdings Inc. Equity WarrantQuarterly Performance Summary & Weekly Watchlist for Consistent Profits - newser.com
Can Tevogen Bio Holdings Inc. stock resist market sell offs2025 Market Sentiment & AI Forecast Swing Trade Picks - newser.com
What makes Tevogen Bio Holdings Inc. (G28) stock appealing to growth investorsQuarterly Profit Report & AI Driven Price Forecasts - newser.com
Is Tevogen Bio Holdings Inc. Equity Warrant stock a buy in volatile markets - newser.com
Can Tevogen Bio Holdings Inc. stock hit record highs againWeekly Trend Summary & Community Consensus Stock Picks - newser.com
Will Tevogen Bio Holdings Inc. stock benefit from green energy trendsJuly 2025 Opening Moves & Verified Chart Pattern Signals - newser.com
Tevogen Bio Holdings Inc Stock (TVGN) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.45%
0.86%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):